An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS
RecruitingOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
January 26, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
August 31, 2026
Conditions
Rheumatoid ArthritisAnkylosing Spondylitis
Trial Locations (1)
Unknown
RECRUITING
Daegu Catholic University Medical Center, Daegu
All Listed Sponsors
lead
Yuhan Corporation
INDUSTRY
NCT05835518 - An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS | Biotech Hunter | Biotech Hunter